Imprivata ramps up authentication platform; will showcase at HIMSS 2016

February 28, 2016 - 

Imprivata has expanded the capabilities of Imprivata Confirm ID, a comprehensive user identity and two-factor authentication platform for the healthcare enterprise, beyond electronic prescribing of controlled substances (EPCS).

Imprivata Confirm ID originally launched in February 2015 as a secure signing solution for EPCS, helping healthcare providers meet DEA requirements for EPCS. The expanded platform now addresses other emerging cybersecurity issues including remote access, medical device security and in-process authentication for clinical transactions, for all enterprise users.

Imprivata Confirm ID replaces passwords with a range of authentication methods including hands free authentication, push token notification, and fingerprint biometrics.

“As healthcare goes digital, critical clinical workflows are using simple, sometimes generic user names and passwords to provide access, making patient information easily vulnerable to hacking,” said Omar Hussain, president and CEO of Imprivata. “Imprivata’s commitment to our customers is to provide innovative authentication solutions that are seamlessly integrated into the care delivery process.”

Hussain continues, “I’m excited that we are building on the phenomenal success we saw with Imprivata Confirm ID in its first year for EPCS by expanding the platform to medical devices and remote access. Our medical device partnership with Capsule is the first of many to show how we can enable our customers to have one user experience for all of their strong authentication needs.”

Using the Capsule SmartLinx Neuron 2 mobile clinical computer, Imprivata Confirm ID now facilitates strong authentication for medical devices to optimize how organizations capture, harness, and unlock the power of patient data.

Imprivata Confirm ID also safeguards patient health information and allows hospitals to meet regulatory compliance requirements by improving visibility into user interactions with patient information on medical devices.

Imprivata will showcase this new integration at HIMSS 2016, which starts this week in Las Vegas.

In March, Imprivata will be hosting a webinar titled “Combat Phishing Attacks and Other Security Threats with Strong, Two-factor Authentication for Healthcare”.

Leave a Comment

comments

About Stephen Mayhew

Stephen Mayhew is the publisher and co-founder of Biometrics Research Group, Inc.. His experience includes a mix of entrepreneurship, brand development and publishing. Stephen attended Carleton University and lives in Toronto, Canada. Connect with Stephen on LinkindIn.